Biotech

All Articles

Cullinan, after $25M bargain, restore bispecific to Port

.Cullinan Therapy was wowed good enough with Port BioMed's bispecific immune system activator that i...

A better take a look at Brutal Biotech's Ferocious 15

.Within this full week's incident of "The Top Line," our experts're diving into Intense Biotech's an...

Lilly experiences period 2 failure of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's event commemorating the commendation of Alzhe...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shootings...

Lykos will definitely talk to FDA to reexamine its own choice following being rejected of MDMA therapy for trauma

.Complying with an inadequate showing for Lykos Therapies' MDMA applicant for trauma at a current FD...

AN 2 halves roll call, stops period 3 trial after data disappoint

.AN2 Therapies is reconsidering its business in reaction to poor midphase data, vowing to lay off ha...

Merck spends $700M for bispecific, spying autoimmune position and also opportunity to test Amgen in cancer

.Merck &amp Co. is paying $700 million in advance to test Amgen in a blood stream cancer market. The...

Gilead pays J&ampJ $320M to exit licensing deal for seladelpar

.Along With Gilead Sciences on the verge of an FDA selection for its own liver health condition drug...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks may see the business putting together tents at basecamp responsible for Eli Lilly i...

Entero laying off personnel, abandoning office and stopping briefly R&ampD

.Mattress Liquidators has actually transformed Entero Therapeutics white as a piece. The financial i...